Clinical Trial Update: Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the therapeutic equivalence of a mometasone furoate nasal spray (50 mcg) with Nasonex nasal spray for seasonal allergic rhinitis has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Mometasone furoate nasal spray (mometasone furoate)
• Nasonex nasal spray (mometasone furoate)

Snippet

Sponsor: Amneal Pharmaceuticals, LLC | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED